New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
08:04 EDTLJPCLa Jolla enters agreement with Stanford University
La Jolla Pharmaceutical announced that it has signed an option agreement with Leland Stanford Junior University that will add proprietary technology to the company’s programs. The option agreement with Stanford allows La Jolla to test the technology potentially adding product opportunities to La Jolla’s pipeline. La Jolla is currently testing novel oral formulations using the technology in an animal model of Non-alcoholic Steatohepatitis. If successful, these product candidates will add to the company’s pipeline.
News For LJPC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 12, 2014
18:29 EDTLJPCOn The Fly: After Hours Movers
Subscribe for More Information
16:18 EDTLJPCLa Jolla reports GCS-100 Phase 2 study met primary endpoint
Subscribe for More Information
16:04 EDTLJPCLa Jolla reports Q3 EPS (37c), consensus (31c)
Subscribe for More Information
November 10, 2014
15:54 EDTLJPCAmerican Society of Nephrology to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use